SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation
about
Role of SOX family of transcription factors in central nervous system tumorsId4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTENProstate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling.Androgen receptor functions in prostate cancer development and progressionReprogramming transcription by distinct classes of enhancers functionally defined by eRNACrosstalk between nuclear MET and SOX9/β-catenin correlates with castration-resistant prostate cancerSOXs in human prostate cancer: implication as progression and prognosis factors.DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma.Molecular pathways and targets in prostate cancerβ-catenin is required for prostate development and cooperates with Pten loss to drive invasive carcinoma.Genetic susceptibility loci, pesticide exposure and prostate cancer risk.Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium.The biology of castration-resistant prostate cancerThe versatile functions of Sox9 in development, stem cells, and human diseasesHigh-calorie diet exacerbates prostate neoplasia in mice with haploinsufficiency of Pten tumor suppressor geneLoss of JUNB/AP-1 promotes invasive prostate cancerTumor-suppressive microRNA-145 induces growth arrest by targeting SENP1 in human prostate cancer cells.Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate CancersAnimal models relevant to human prostate carcinogenesis underlining the critical implication of prostatic stem/progenitor cells.Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival.Oncogenicity of the developmental transcription factor Sox9.Sox9 is required for prostate development and prostate cancer initiationDecreased expression of SOX9 indicates a better prognosis and inhibits the growth of glioma cells by inducing cell cycle arrestIdentification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancerAnimal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee.Recent progress in mouse models for tumor suppressor genes and its implications in human cancer.The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients.Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axisBiomarkers in prostate cancer epidemiology.Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancer.Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.The SOX family of genes in cancer development: biological relevance and opportunities for therapy.Modeling prostate cancer in mice: something old, something new, something premalignant, something metastatic.AR function in promoting metastatic prostate cancerDisruption of long-range gene regulation in human genetic disease: a kaleidoscope of general principles, diverse mechanisms and unique phenotypic consequences.The Role of Tricho-Rhino-Phalangeal Syndrome (TRPS) 1 in Apoptosis during Embryonic Development and Tumor Progression.Androgen receptor epigenetics.
P2860
Q26860974-4BC4AB6B-8EAB-4C3D-881E-7FC889786D8DQ28592943-E0EC9DDB-1A1F-4D6D-B77D-7604322A1AECQ33640983-02112B35-B866-4D58-B0A7-F53BC51C940AQ33677421-1A679562-958D-4F37-96D7-4B5756C79706Q33688960-89DDF32B-C6E6-4D5E-86FC-0FAC94608097Q33922393-954C134F-9FE2-48D7-8B6B-973FF22DFAC2Q34185076-5D719534-0D09-410C-A3DB-3E093D35EB82Q34265065-02BAEC14-5BF1-4F5C-9321-35B25D4D97A1Q34306308-A8C699F4-E057-40F7-BABB-707272D82A5FQ34360406-C1DF55AC-FAED-4902-8AAA-F1C26926FB7BQ34365632-39F00047-5D45-4643-8F14-D212D903EC53Q34539930-04F4FDF4-8CF5-463D-BEB2-EEEBBFDCC230Q34672214-EBB12447-1B82-4989-90DD-BE4110BA8E77Q34876177-BE0F4C25-8972-408F-BD80-0C6F40A77699Q35039889-E9645487-F6AA-4BF2-812F-7764203F2D8CQ35077784-49131217-E284-4D98-B846-EB6624BC5BFCQ35113473-41925EFC-8603-4AF5-A236-18E6FE06C553Q35167623-078C7B54-1D42-4D39-8D42-E78C7C15270BQ35538436-A0F49697-1431-46E9-8A47-AAFD6ED844EBQ35648290-9CDAA060-1F7B-4F28-83DB-AC5978D26BF1Q35746535-1F966CB1-3D58-44D4-9584-6E23394FDA21Q35856469-F0C592B7-E50A-4EB8-BF39-F73F457DA312Q36043468-2A8A19B2-F700-4399-B70C-49343987621AQ36234048-C7D768D6-C4F8-4806-9ED4-69BC640DD141Q36261289-414FBCB2-1537-4F0A-917A-0E79F03B23CBQ36299781-D9127407-FCEC-4ED0-8E9F-4D7856730233Q36638207-D2DEE1C8-AE0A-4987-A5B9-49A8A04192FEQ36815316-900E7010-E0DA-44AA-8CA8-206257AF6C62Q36929407-774F5F2F-4E31-4649-9F2F-5CF98450F9D0Q36959130-1F1A3AE5-D902-4CC5-BCCB-4FE1B32FB02EQ36961208-97562F3F-4199-4963-ACB6-A74969D78401Q37148139-257E3FA1-8D4A-47A3-A382-408FC46CAC7CQ37537822-D78C45AD-81D3-4BA7-AAC1-5628D6AFA557Q37702315-7879C62C-CD1E-484C-ABC4-14DB15C8B916Q38029732-E4396ECC-F5AD-4254-81FE-65917A7E9ACDQ38056848-E3FDB437-45B6-4B58-B5AF-375C4E2B582FQ38178555-4A5BEEBE-B18D-4A67-86A3-99F33FE0D3E1Q38185270-A24686B0-B73A-427C-BC66-3AEC03A5CFFFQ38202820-5D2CFEEF-1927-4D86-8743-53755E0E90ABQ38314940-1DBB9BA7-AF81-4461-A68A-6CB2F0FD5779
P2860
SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
SOX9 elevation in the prostate ...... loss to drive tumor formation
@ast
SOX9 elevation in the prostate ...... loss to drive tumor formation
@en
SOX9 elevation in the prostate ...... loss to drive tumor formation
@en-gb
SOX9 elevation in the prostate ...... loss to drive tumor formation
@nl
type
label
SOX9 elevation in the prostate ...... loss to drive tumor formation
@ast
SOX9 elevation in the prostate ...... loss to drive tumor formation
@en
SOX9 elevation in the prostate ...... loss to drive tumor formation
@en-gb
SOX9 elevation in the prostate ...... loss to drive tumor formation
@nl
prefLabel
SOX9 elevation in the prostate ...... loss to drive tumor formation
@ast
SOX9 elevation in the prostate ...... loss to drive tumor formation
@en
SOX9 elevation in the prostate ...... loss to drive tumor formation
@en-gb
SOX9 elevation in the prostate ...... loss to drive tumor formation
@nl
P2093
P2860
P50
P921
P1433
P1476
SOX9 elevation in the prostate ...... loss to drive tumor formation
@en
P2093
Christopher M Butler
Christopher S Foster
Colin S Cooper
Gabrielle Fisher
Henrik Møller
Jack Cuzick
Kathryn S E Cheah
Laurence Ambroisine
Narasimhan Ragavan
Paras B Singh
P2860
P304
P356
10.1158/0008-5472.CAN-09-2370
P407
P577
2010-02-01T00:00:00Z